The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sequential active chemotherapy schema in castration-resistant prostate cancer.
R. Tang
No relevant relationships to disclose
S. G. Groshen
No relevant relationships to disclose
C. I. Piatek
No relevant relationships to disclose
B. B. Desai
No relevant relationships to disclose
J. K. Pinski
No relevant relationships to disclose
F. Acosta
No relevant relationships to disclose
D. Raghavan
No relevant relationships to disclose
T. B. Dorff
No relevant relationships to disclose
D. I. Quinn
No relevant relationships to disclose